The liver is the sixth most common site of primary cancer in humans and the fourth leading
cause of cancer‐related death in the world. Hepatocellular carcinoma (HCC) accounts for …

Abstract The discipline of Cardio-Oncology has seen tremendous growth over the past
decade. It is devoted to the cardiovascular (CV) care of the cancer patient, especially to the …

Abstract Each year, the American Cancer Society estimates the numbers of new cancer
cases and deaths in the United States and compiles the most recent data on population …

Hepatocellular carcinoma (HCC), the fourth leading cause of cancer mortality worldwide,
develops almost exclusively in patients with chronic liver disease and advanced fibrosis …

In this report, the authors provide comprehensive and up‐to‐date US data on disparities in
cancer occurrence, major risk factors, and access to and utilization of preventive measures …

Each year, the American Cancer Society estimates the numbers of new cancer cases and
deaths in the United States and compiles the most recent data on population-based cancer …

PURPOSE The systematic collection of data on cancer is being performed by various
population-based cancer registries (PBCRs) and hospital-based cancer registries (HBCRs) …

The growing knowledge of ferroptosis has suggested the role and therapeutic potential of
ferroptosis in cancer, but has not been translated into effective therapy. Liver cancer …

Hepatocellular carcinoma (HCC) is a highly heterogeneous disease, which makes the
prognostic prediction challenging. Ferroptosis, an iron-dependent form of regulated cell …

Background: The prevalence of cancer survivorship is increasing. In this study, we provide
contemporary population–based estimates and projections of the overall and site-specific …